Finanshus nedjusterer Genmab til kurs 1000
1/4 14:44
Bernstein Downgrades Genmab to Underperform, Cuts PT Bernstein on Tuesday lowered Danish biotechnology company Genmab (GMAB.CO) to underperform from market perform and reduced its price target to 1,000 Danish kroner from 1,580 kroner....